These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9579771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR, Chen CH, Ding PY, Chen YT, Ting CT, Huang JL, Chiang AH, Liu CP, Tseng CJ, Chao CT, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
    Tikkanen I, Omvik P, Jensen HA.
    J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
    [Abstract] [Full Text] [Related]

  • 6. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
    Larochelle P, Flack JM, Marbury TC, Sareli P, Krieger EM, Reeves RA.
    Am J Cardiol; 1997 Dec 15; 80(12):1613-5. PubMed ID: 9416950
    [Abstract] [Full Text] [Related]

  • 7. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M.
    J Hypertens; 1998 Mar 15; 16(3):385-93. PubMed ID: 9557932
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertension.
    Stumpe KO, Haworth D, Hoglund C, Kerwin L, Martin A, Simon T, Masson C, Kassler-Taub K, Osbakken M.
    Blood Press; 1998 Jan 15; 7(1):31-7. PubMed ID: 9551875
    [Abstract] [Full Text] [Related]

  • 9. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
    Oparil S, Guthrie R, Lewin AJ, Marbury T, Reilly K, Triscari J, Witcher JA.
    Clin Ther; 1998 Jan 15; 20(3):398-409. PubMed ID: 9663357
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
    Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E.
    Am J Hypertens; 1998 Apr 15; 11(4 Pt 1):445-53. PubMed ID: 9607383
    [Abstract] [Full Text] [Related]

  • 11. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
    Pool JL, Guthrie RM, Littlejohn TW, Raskin P, Shephard AM, Weber MA, Weir MR, Wilson TW, Wright J, Kassler-Taub KB, Reeves RA.
    Am J Hypertens; 1998 Apr 15; 11(4 Pt 1):462-70. PubMed ID: 9607385
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.
    Malmqvist K, Kahan T, Dahl M.
    Am J Hypertens; 2000 May 15; 13(5 Pt 1):504-11. PubMed ID: 10826401
    [Abstract] [Full Text] [Related]

  • 13. Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
    Neutel JM, Germino FW, Smith D.
    J Renin Angiotensin Aldosterone Syst; 2005 Sep 15; 6(2):84-9. PubMed ID: 16470487
    [Abstract] [Full Text] [Related]

  • 14. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
    Byyny RL, Merrill DD, Bradstreet TE, Sweet CS.
    Cardiovasc Drugs Ther; 1996 Jul 15; 10(3):313-9. PubMed ID: 8877074
    [Abstract] [Full Text] [Related]

  • 15. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group.
    Zanchetti A, Omboni S.
    Am J Hypertens; 2001 Feb 15; 14(2):129-34. PubMed ID: 11243303
    [Abstract] [Full Text] [Related]

  • 16. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 15; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.
    Ruff D, Gazdick LP, Berman R, Goldberg AI, Sweet CS.
    J Hypertens; 1996 Feb 15; 14(2):263-70. PubMed ID: 8728306
    [Abstract] [Full Text] [Related]

  • 18. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
    Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP.
    Circulation; 2005 Mar 01; 111(8):1012-8. PubMed ID: 15723979
    [Abstract] [Full Text] [Related]

  • 19. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P, Guthrie R, Flack J, Reeves R, Saini R.
    J Hum Hypertens; 1999 Oct 01; 13(10):683-7. PubMed ID: 10516738
    [Abstract] [Full Text] [Related]

  • 20. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan.
    Mancia G, Korlipara K, van Rossum P, Villa G, Silvert B.
    Blood Press Monit; 2002 Apr 01; 7(2):135-42. PubMed ID: 12048432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.